Nontuberculous Mycobacterial Ocular Infections: A Systematic Review of the Literature

Table 4

Medical treatment of NTM keratitis.

Mode of delivery	Number of eyes
Topical	108 (53.2%)
Topical and systemic	85 (41.9%)
Systemic	5 (2.5%)
Topical, systemic, and periocular	2 (1%)
Topical and intraocular	1 (0.5%)
Topical and periocular	1 (0.5%)
Systemic and periocular	1 (0.5%)
Antibiotic (ATB) regimen	Number of eyes
Amikacin alone	56 (29.2%)
Amikacin + macrolide	27 (14.1%)
Amikacin + fluoroquinolone	24 (12.5%)
Amikacin + fluoroquinolone + macrolide	18 (9.4%)
Fluoroquinolone + macrolide	16 (8.3%)
Other^*	14 (7.3%)
Fluoroquinolone alone	13 (6.8%)
Amikacin + 1 or more ATB^*	11 (5.7%)
Macrolide + 1 or more ATB^*	7 (3.6%)
Macrolide alone	5 (2.6%)
Fluoroquinolone + 1 more ATB^*	1 (0.5%)

 ^*Antibiotic not including amikacin/fluoroquinolone/macrolide.